Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer
Clinical trial NCT00678535 · COMPLETED
Trial details
- NCT number
- NCT00678535
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2012-03-01
- Enrollment
- 904
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.